Converting Tramadol to Fentanyl Patch for Pain Management

Conversion Algorithm

The National Comprehensive Cancer Network recommends calculating the total daily tramadol dose and converting it to oral morphine equivalent to select the appropriate fentanyl patch strength, with 400 mg/day oral tramadol being approximately equivalent to 60 mg/day oral morphine 1, 2
The National Comprehensive Cancer Network suggests that 200 mg/day oral tramadol is approximately equivalent to 30 mg/day oral morphine 2
The National Comprehensive Cancer Network recommends the following conversion table: 60 mg/day oral morphine ≈ 25 mcg/h fentanyl patch, 120 mg/day oral morphine ≈ 50 mcg/h fentanyl patch, 180 mg/day oral morphine ≈ 75 mcg/h fentanyl patch, and 240 mg/day oral morphine ≈ 100 mcg/h fentanyl patch 2
The National Comprehensive Cancer Network provides specific tramadol to fentanyl patch conversion guidelines, including 200 mg/day oral tramadol ≈ 25 mcg/h fentanyl patch, 400 mg/day oral tramadol ≈ 50 mcg/h fentanyl patch, 600 mg/day oral tramadol ≈ 75 mcg/h fentanyl patch, and 800 mg/day oral tramadol ≈ 100 mcg/h fentanyl patch 1, 2

The National Comprehensive Cancer Network recommends reducing the initial dose by 25-50% to account for incomplete cross-tolerance between different opioids, especially if pain was previously well-controlled 3, 4
The National Comprehensive Cancer Network suggests providing breakthrough medication during transition, with short-acting opioid prescribed for breakthrough pain, particularly during the first 8-24 hours 2, 3
The National Comprehensive Cancer Network advises ensuring pain is relatively well-controlled on short-acting opioids before initiating fentanyl patch, and using fentanyl patch only in opioid-tolerant patients 1, 2
The National Comprehensive Cancer Network recommends avoiding application of heat as it accelerates fentanyl absorption, and closely monitoring patients for side effects during the first 24-72 hours of transition 2

The National Comprehensive Cancer Network recommends adjusting patch dosage based on breakthrough medication requirements after 2-3 days, and considering replacement every 48 hours for some patients 2, 3
The National Comprehensive Cancer Network suggests continuing breakthrough medication once patch dose is stabilized 3

The National Comprehensive Cancer Network advises starting with conservative dosing and titrating up as needed to prevent respiratory depression, and closely monitoring patients for side effects during the first 24-72 hours of transition 2